Pharma Companies That Ignore AI Monitoring Will Lose Narrative Control
When a physician in Ohio types “best GLP-1 for weight loss” into Perplexity and receives a two-paragraph synthesis with no […]
When AI Gets Drugs Wrong: Real Hallucination Examples and What Pharma Can Do Now
ChatGPT has told patients that Ozempic is FDA-approved for weight loss in children. Gemini has cited drug interaction warnings that
How Pharma Companies Monitor AI Discussions Around Patent Expirations and Generic Drug Threats
When a blockbuster drug loses patent protection, the conversation used to start at the pharmacy counter. A patient picks up
Why GLP-1 Drugs Generate More AI Health Queries Than Any Other Drug Class
Type any variation of ‘weight loss drug’ into ChatGPT, Gemini, Perplexity, or Claude and you will get semaglutide within the
How Drug Companies Use AI Monitoring to Protect Brand, Safety, and Market Share
In 2023, a patient in a Reddit thread described asking ChatGPT about Ozempic dosing. The AI told her it was
Which Drug Categories AI Hallucinates Most — and What Pharma Must Do Now
In March 2024, a cardiologist in Houston noticed something odd. A patient arrived at their appointment quoting drug interaction warnings
LLMs vs. Pharma Websites: Which Explains Drug Side Effects Better — And What It Costs Brands
Ask the official Humira website what side effects patients should expect. You will get a dense PDF, a legal disclaimer,
AI Is Rewriting Your Drug Label — Without Asking
Every day, tens of millions of patients and physicians type drug questions into ChatGPT, Gemini, Claude, and Perplexity. They get
The Pharma AI Visibility Problem: Why Your Drug Is Losing Ground in ChatGPT, Gemini, and Claude — And What to Do About It
Six months ago, a brand director at a mid-sized specialty pharma company asked ChatGPT what the leading treatment options were
AI Became Your Patient’s Drug Counselor. Pharma Didn’t Get a Vote.
Somewhere between the formulary decision and the first filled prescription, a patient opens ChatGPT and asks: “Is Ozempic safe for
AI Models Are Training on Old Drug Information. Here’s the Risk.
In March 2023, FDA updated the labeling for tofacitinib (Xeljanz) to strengthen a boxed warning about serious cardiac events, malignancy,
How to Benchmark AI Responses Against FDA Labels: A Pharma Brand Team’s Playbook
When a physician types “what is the maximum dose of Jardiance in heart failure” into ChatGPT, the answer that comes
